Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer https://www.biorxiv.org/content/10.1101/2023.06.27.546750v1?med=mas
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer https://www.biorxiv.org/content/10.1101/2023.06.27.546750v1?med=mas